Harold Simmons Center for Kidney Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California Irvine, Orange, CA, USA; Long Beach Veterans Affairs Healthcare System, Long Beach, CA, USA.
Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Bone. 2019 Jul;124:158-165. doi: 10.1016/j.bone.2019.03.003. Epub 2019 Mar 9.
Vitamin D deficiency is common among dialysis patients and may impact blood concentrations of calcium, phosphorus, intact parathyroid hormone (iPTH), and alkaline phosphatase (ALP). Seasonal variation of serum 25-hydroxyvitamin D [25(OH)D] concentrations has been well established for the general population; however, less is known about circannual variation in 25(OH)D as well as other parameters of mineral and bone disorder among dialysis patients.
Based on 57,500 serum 25(OH)D measurements collected over two years from January 2009 to December 2010 among 25,025 dialysis patients, we evaluated the circannual variations in serum concentrations of 25(OH)D, calcium, phosphorus, iPTH, and ALP by a linear regression model with a cosinor function for the time period (month). We adjusted for potential confounders including case-mix variables, and ultraviolet index.
Serum 25(OH)D concentrations showed significant circannual variation and mean serum 25(OH)D was 3.2 ng/mL higher in summer than in winter. Furthermore, 25(OH)D concentration increased steadily by 1.3 ng/mL per year. While serum calcium concentrations showed statistically significant but clinically negligible seasonal variation (0.02 mg/dL in peak-trough difference), serum phosphorus did not follow such a pattern. Serum iPTH concentrations also showed a modest seasonal variation with 9% higher values in winter than in summer. Concordantly, ALP concentrations in the winter were 2% higher than in the summer time. Seasonal variation of 25(OH)D was greater in male (vs. female), African-American (vs. non-African-American), and younger (vs. older) dialysis patients.
Serum 25(OH)D and iPTH concentrations show seasonal variation among dialysis patients while the variation in other parameters of mineral and bone disorder was clinically irrelevant, if any. Serum 25(OH)D also showed a gradual increase over time. Clinicians and researchers should be aware of these changes when interpreting laboratory results in dialysis patients.
维生素 D 缺乏在透析患者中很常见,可能会影响血钙、血磷、全段甲状旁腺激素(iPTH)和碱性磷酸酶(ALP)的血浓度。一般人群的血清 25-羟维生素 D [25(OH)D] 浓度的季节性变化已有充分的研究;然而,关于透析患者的 25(OH)D 以及其他矿物质和骨代谢紊乱参数的年周期变化知之甚少。
基于 2009 年 1 月至 2010 年 12 月期间 25025 例透析患者的 57500 次血清 25(OH)D 测量值,我们通过线性回归模型和余弦函数评估了血清 25(OH)D、钙、磷、iPTH 和 ALP 的年周期变化。我们调整了潜在的混杂因素,包括病例组合变量和紫外线指数。
血清 25(OH)D 浓度存在显著的年周期变化,夏季血清 25(OH)D 平均浓度比冬季高 3.2ng/mL。此外,25(OH)D 浓度每年稳定增加 1.3ng/mL。虽然血清钙浓度的季节性变化具有统计学意义,但临床意义不大(峰谷差值为 0.02mg/dL),血清磷则没有这种模式。iPTH 浓度也有适度的季节性变化,冬季比夏季高 9%。相应地,冬季的 ALP 浓度比夏季高 2%。25(OH)D 的季节性变化在男性(与女性相比)、非裔美国人(与非非裔美国人相比)和较年轻(与较年长)的透析患者中更大。
血清 25(OH)D 和 iPTH 浓度在透析患者中存在季节性变化,而其他矿物质和骨代谢紊乱参数的变化如果存在的话则无临床意义。血清 25(OH)D 也随着时间的推移逐渐增加。临床医生和研究人员在解释透析患者的实验室结果时应注意这些变化。